NET PROFIT (x1000 SEK)
EMPLOYEES
Invivo Medisinske Senter AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
4
|
4
|
4 |
| Earnings before taxes |
-2
|
0
|
0 |
| Total assets |
712
|
798
|
658 |
| Current assets |
654
|
725
|
609 |
| Current liabilities |
557
|
629
|
492 |
| Equity capital |
155
|
169
|
166 |
| - share capital |
148
|
159
|
154 |
| Employees (average) |
7
|
8
|
8 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.8%
|
21.2%
|
25.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
0.3%
|
0.5%
|
0.6% |
| Current ratio |
117.4%
|
115.3%
|
123.8% |
| Return on equity (ROE) |
-1.3%
|
0%
|
0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
0 | |
| Chg. No. of employees % |
-13%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.